Novaled AG has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering (IPO) of its American Depositary Shares (ADSs). Novaled is a leader in the research, development and commercialization of technologies and materials that enhance the performance of organic light-emitting diodes, or OLEDs, and other organic electronics.
Novaled intends to apply to have its ADSs listed on the NASDAQ Global Market or New York Stock Exchange. Goldman, Sachs & Co. and Deutsche Bank Securities are acting as joint book-running managers for the offering. Canaccord Genuity, Commerzbank, Cowen and Company and JMP Securities are acting as co-managers.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.
The registration statement may be accessed directly through the U.S. Securities and Exchange Commission at www.sec.gov .
Novaled AG is currently the only company licensing and selling organic conductivity doping technology and materials for use in the commercial mass production of display products in the OLED industry.
Novaled has developed strategic partnerships with key OLED innovators and producers throughout the world and, with a broad portfolio of more than 500 patents granted or pending, has a strong IP position in OLED technologies, structures and materials.
For more information, please visit www.novaled.com .
For more attend: Printed Electronics Europe 2012.